Heritable pulmonary arterial hypertension+2
Not recruitingStudy on Dapagliflozin for Patients with Pulmonary Arterial Hypertension to Improve Exercise Capacity and Heart Function
Study on Dapagliflozin for Patients with Pulmonary Arterial Hypertension to Improve Exercise Capacity and Heart Function
- Disease:Heritable pulmonary arterial hypertensionPulmonary arterial hypertension+1
- Substances:DapagliflozinPlacebo
Denmark- Participants:18–64 years · 65+ years
- Substances:Dapagliflozin
- Sponsor:Region Hovedstaden










